CD8A and neoplasm: Additionally, vinburnine activates the P38/MAPK/ATF3 signaling axis, which drives the secretion of interleukin-24 (IL-24), enhancing the functionality of CD8+ T cells and modulating the tumor immune microenvironment to favor antitumor immunity.